---
$id: https://graph.org.ai/products/commodity/51401508
$type: Product
source: UNSPSC
code: "51401508"
title: "Lormetazepam"
class: "51401500"
classTitle: "Tranquilizers and antimanic and antianxiety benzodiazepines"
family: "51400000"
familyTitle: "Tranquilizers and antimanic and antianxiety drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lormetazepam

**UNSPSC Code**: 51401508
**Class**: [Tranquilizers and antimanic and antianxiety benzodiazepines](Tranquilizers and antimanic and antianxiety benzodiazepines.mdx)
**Family**: [Tranquilizers and antimanic and antianxiety drugs](../Tranquilizers and antimanic and antianxiety drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a benzodiazepine with the molecular formula C16H12Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GU56C842ZA, chemically known as 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2h-1,4-benzodiazepin-2-one but generally known as lormetazepam, which bears US NIH Compound Identifier 13314. European Medicines Agency schedules Lormetazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08588MIG. The term LORMETAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules lormetazepam in its Anatomical Therapeutic Chemical (ATC) Classification. LORMETAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lormetazepam under HS 29339190 and SITC 51577. As of Q4 2014, LORMETAZEPAM remains the US FDA Preferred Term for this commodity. Lormetazepam bears US NLM identifiers UMLS ID C0065185 and NCI Concept Code C87673. SMILES: CLC1CC2C(N(C(=O)C(O)N=C2C2C(CL)CCCC2)C)CC1.

